%20--%3e%3csvg%20version='1.1'%20id='svg4774'%20xmlns:rdf='http://www.w3.org/1999/02/22-rdf-syntax-ns%23'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns:cc='http://creativecommons.org/ns%23'%20xmlns:svg='http://www.w3.org/2000/svg'%20xmlns:dc='http://purl.org/dc/elements/1.1/'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20inkscape:version='0.92.4%205da689c313,%202019-01-14'%20sodipodi:docname='a.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20213.2%20213.2'%20style='enable-background:new%200%200%20213.2%20213.2;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:%2300295B;}%20.st1{fill:%234D8BFF;}%20.st2{fill:%231F63D1;}%20%3c/style%3e%3csodipodi:namedview%20bordercolor='%23666666'%20borderopacity='1.0'%20fit-margin-bottom='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-top='0'%20id='base'%20inkscape:current-layer='layer1'%20inkscape:cx='-2.0433735'%20inkscape:cy='114.2263'%20inkscape:document-units='mm'%20inkscape:pageopacity='0.0'%20inkscape:pageshadow='2'%20inkscape:window-height='1358'%20inkscape:window-maximized='0'%20inkscape:window-width='2560'%20inkscape:window-x='0'%20inkscape:window-y='36'%20inkscape:zoom='1.979899'%20pagecolor='%23ffffff'%20showgrid='false'%3e%3c/sodipodi:namedview%3e%3crect%20id='rect5343'%20class='st0'%20width='213.2'%20height='213.2'/%3e%3cg%3e%3cpath%20id='path1193_00000097479180809850930690000003643395657245599423_'%20class='st1'%20d='M29.3,144.7h29c6.7,0.4,13.2-2.2,17.8-7%20c5.4-6,5.6-17.3,5.6-31.7S81.4,81.6,76,75.6c-4.6-4.9-11.1-7.4-17.8-7h-29V54.3h30.6c10-0.5,19.7,3.1,27,9.8%20c11.3,11.3,10.6,26.6,10.6,41.7s0.7,31.9-10.6,43.2c-7.3,6.8-17.1,10.3-27,9.8H29.3V144.7z%20M115.9,54.3h37.2%20c19.4,0,31.6,11,31.6,28.6c0.2,9.6-5.4,18.3-14.1,22.2c9.9,3.9,16.2,13.6,15.7,24.2c0,19.2-13.1,29.5-31.6,29.5h-38.8v-14.2h37.3%20c11,0,17.2-6.8,17.2-16s-6.2-15.9-17.2-15.9h-21.4V98.6h19.9c10.1,0,17-5.3,17-15s-6.9-15-17-15h-35.8V54.3z'/%3e%3cpath%20id='path1195_00000043421768087631810500000010918890743570938541_'%20class='st2'%20d='M45.2,54.3H29.3v104.6h15.9V54.3z%20M131.8,54.3h-15.9v104.6h15.9V54.3z'/%3e%3c/g%3e%3c/svg%3e)
[100.104.30.3002.300290] Bulgaria – Myanmar – Pharmaceutical products – Human blood: animal blood for therapeutic, prophylactic or diagnostic uses: antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes: vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc – Toxins, cultures of micro-organisms (excluding yeasts) and similar products
Retrieved by DBnomics on March 16, 2023 (10:59 AM)
- from
- 2017=31.8
- to
- 2017=31.8
- min:
- 31.8
- max:
- 31.8
- avg:
- 31.8
- σ:
- 0
Loading chart